TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
PCI Biotech Holding ASA
Closing information (x1000 DKK)
| Closing information | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
| Turnover |
7,113
|
7,136
|
7,755 |
| Financial expenses |
2,030
|
112
|
66 |
| Earnings before taxes |
-67,213
|
-25,895
|
-32,412 |
| Total assets |
213,602
|
265,839
|
44,211 |
| Current assets |
208,844
|
265,827
|
44,194 |
| Current liabilities |
18,652
|
12,653
|
11,035 |
| Equity capital |
193,000
|
253,106
|
31,657 |
| - share capital |
84,672
|
83,011
|
56,713 |
| Employees (average) | 0 | ||
| Shareholders | 0 | 0 | 0 |
Financial ratios
| Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
| Solvency |
90.4%
|
95.2%
|
71.6% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-944.9%
|
-362.9%
|
-417.9% |
| Return on assets (ROA) |
-30.5%
|
-9.7%
|
-73.2% |
| Current ratio |
1119.7%
|
2100.9%
|
400.5% |
| Return on equity (ROE) |
-34.8%
|
-10.2%
|
-102.4% |
| Change turnover |
-146
|
-495
|
-170 |
| Change turnover % |
-2%
|
-6%
|
-2% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.